7.31
Cullinan Therapeutics Inc 주식(CGEM)의 최신 뉴스
Heatmap analysis for Cullinan Therapeutics Inc. and competitorsQuarterly Earnings Summary & Entry Point Confirmation Alerts - newser.com
Cullinan Therapeutics Inc. stock daily chart insightsTrade Exit Report & Safe Capital Growth Tips - newser.com
Will Cullinan Therapeutics Inc. stock maintain dividend yieldJuly 2025 EndofMonth & High Win Rate Trade Alerts - fcp.pa.gov.br
Why Cullinan Therapeutics Inc. stock remains undervaluedJuly 2025 Rallies & Expert Approved Momentum Ideas - fcp.pa.gov.br
Can Cullinan Therapeutics Inc. stock beat market expectations this quarterJuly 2025 Fed Impact & Growth Focused Entry Point Reports - newser.com
Cullinan Therapeutics Inc. stock outlook for YEARQuarterly Risk Review & Low Volatility Stock Recommendations - newser.com
Can Cullinan Therapeutics Inc. stock attract ESG capital inflowsWall Street Watch & Accurate Entry/Exit Alerts - newser.com
Is Cullinan Therapeutics Inc. trending in predictive chart modelsWeekly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
Using data filters to optimize entry into Cullinan Therapeutics Inc.July 2025 Weekly Recap & Fast Exit/Entry Strategy Plans - newser.com
How Cullinan Therapeutics Inc. stock trades during market volatilityJuly 2025 News Drivers & Weekly High Return Stock Forecasts - newser.com
Visual analytics tools that track Cullinan Therapeutics Inc. performanceJuly 2025 Rallies & Stepwise Trade Signal Implementation - newser.com
Cullinan Therapeutics Inc. stock trend forecastQuarterly Portfolio Report & AI Enhanced Trade Execution Alerts - newser.com
Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Cullinan Management (CGEM) and Idexx Laboratories (IDXX) - The Globe and Mail
Is Cullinan Therapeutics Inc. stock a good choice for value investorsWeekly Market Report & High Accuracy Investment Signals - newser.com
Will Cullinan Therapeutics Inc. stock recover after recent dropJuly 2025 Update & Daily Entry Point Alerts - newser.com
Cullinan Therapeutics (CGEM) Reveals Promising Phase 1 Data for CLN-049 in AML and MDS - GuruFocus
Cullinan Management Unveils Promising CLN-049 Clinical Data - TipRanks
Cullinan Therapeutics Presents New Data on CLN-049 at ASH Meeting - TradingView
Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting - GlobeNewswire
Cullinan (NASDAQ: CGEM) announces 69% ORR for CLN-049 in r/r AML; Phase 1 shows manageable safety - Stock Titan
Is Cullinan Therapeutics Inc. reversing from oversold territory2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com
What machine learning models say about Cullinan Therapeutics Inc.2025 Top Decliners & Reliable Price Breakout Alerts - newser.com
Will Cullinan Therapeutics Inc. rebound enough to break evenWeekly Earnings Recap & Safe Entry Momentum Tips - newser.com
What makes Cullinan Therapeutics Inc. stock attractive to growth fundsQuarterly Profit Report & AI Driven Price Forecasts - newser.com
Backtesting results for Cullinan Therapeutics Inc. trading strategies2025 Volume Leaders & Real-Time Volume Analysis - newser.com
Why retail investors pile into Cullinan Therapeutics Inc. stockProduct Launch & Free Reliable Trade Execution Plans - newser.com
Will Cullinan Therapeutics Inc. stock gain from government policiesEarnings Overview Summary & Reliable Price Breakout Alerts - newser.com
Cullinan Therapeutics (NASDAQ:CGEM) Shares Up 13.5% After Insider Buying Activity - MarketBeat
자본화:
|
볼륨(24시간):